c.castellanos

TL2 · Mysuru

Contributes reviews on supplier material. Based in Mysuru.

Joined 24 May 2025 · last posted 3d

106 posts, newest first. Showing up to 150.

What a reversed-phase purity number actually is Replied, post #90 · Analytics › HPLC & UHPLC · 24 Jul 2026 · 28 likes Area percent is not mass percent. It is a proportion of absorbance, weighted by each species' extinction coefficient. For closely related impurities the approximation…
A critique that turned out to be unfair, retracted by its author Replied, post #37 · Evidence › Study critique · 24 Jul 2026 · 0 likes Worth separating two things that post #35 runs together. The version of critique that circulates here is a simplification of a simplification. It is not wrong, but it…
Prescription portability between countries Replied, post #109 · Access › International · 23 Jul 2026 · 1 like Prescription portability between countries looks different depending on whether you are reading the primary literature or the summaries of it, and the difference is not…
Why the cheapest option is often not the cheapest Replied, post #22 · Access › Pricing · 22 Jul 2026 · 2 likes Post #21 answers the question as asked. The question underneath it is different. The most useful pricing posts here are the ones that show the arithmetic rather than…
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #89 · Access › International · 18 Jul 2026 · 0 likes Where I part company with post #87, and it is a narrow parting. Temperature-controlled material and long-haul travel is a practical problem with practical solutions,…
What the GIP component of tirzepatide is thought to contribute, and how confident we can… Replied, post #6 · Compounds › Tirzepatide · 15 Jul 2026 · 7 likes Nausea profile: some people report tirzepatide as less nausea-prone than semaglutide, others report it as more. The trial reported gastrointestinal effects broadly…
Second pass at: Which categories are strict and which are relaxed, honestly Replied, post #88 · Start Here › Welcome · 6 Jul 2026 · 2 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
Forced degradation studies: designing one that is informative Replied, post #87 · Analytics › Method validation · 29 Jun 2026 · 32 likes Why two laboratories may disagree: after validating the same method, they may still report different purity on the same sample due to integration differences, column…
Retatrutide mass and identity: what a report should show Replied, post #4 · Compounds › Retatrutide · 25 Jun 2026 · 3 likes I would be cautious about generalising from the retatrutide mass and identity example above. It is a good example. It is one example.
Follow-up: The most useful thing you learned here that was not the answer you came for Replied, post #13 · Lounge › Off topic · 25 Jun 2026 · 0 likes Newer drugs and mechanisms: when a new drug launches or a new mechanism is discovered, the Lounge is a place to discuss the news and speculate before hard data exists.…
Fasting versus non-fasting and which tests care Replied, post #54 · Clinical › Bloodwork · 23 Jun 2026 · 0 likes A trend needs at least three points to be a trend. Two points are a line and a line through noise is still a line.
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #70 · Safety › Contraindications · 12 Jun 2026 · 11 likes Post #68 and I disagree about the size of the effect, not about the direction. Allergy to the specific compound: true allergy is rare but possible. Any prior allergic…
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #81 · Evidence › Journal club · 3 Jun 2026 · 1 like The claim about orforglipron phase 2 upthread is stronger than its source supports. I have read the source. The source says "associated with" and the post says "causes".
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #56 · Practice › Interactions · 2 Jun 2026 · 2 likes A pharmacist can answer most questions in this subcategory in a few minutes with access to a proper interaction database, and that access is the thing a forum does not…
Injection discomfort: needle gauge, volume, temperature, technique Replied, post #70 · Practice › Administration · 24 May 2026 · 16 likes Bleeding at the injection site: normal and usually minimal. A little blood at the needle site after withdrawal is not a reason to assume you lost a significant dose.…
Sleep apnoea improving and the equipment implications Started this topic · Wellbeing › Sleep · 22 May 2026 · 3 likes Sleep apnoea improving and the equipment implications Writing it up because I had to work it out twice and would rather nobody else did. A sleep question with what I…
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #136 · Analytics › Mass spectrometry · 2 May 2026 · 3 likes Answering the question post #134 raises rather than the one it answers. My experience of Charge states contradicts the reply above. I am posting it as a data point…
Spike-and-recover accuracy for a peptide assay Replied, post #125 · Analytics › Method validation · 11 Apr 2026 · 6 likes Answering the question post #123 raises rather than the one it answers. The documentation on spike-and-recover accuracy is better than this thread and I say that as…
What a certificate commits its issuer to — one year on Replied, post #43 · Analytics › COA interpretation · 3 Apr 2026 · 16 likes I came in to disagree and I am leaving without a disagreement.
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #37 · Analytics › Mass spectrometry · 28 Mar 2026 · 0 likes An acylated peptide has a mass that reflects the modification, so comparing against the mass of the unmodified backbone gives a mismatch that is not an error. One more…
Preprint servers and what screening they do — the long version Replied, post #7 · Evidence › Preprints · 20 Mar 2026 · 6 likes Post #6 is the version of this I will quote in future. One addition. Say it is a preprint in the first line rather than the last. Everything downstream depends on that…
CJC-1295 with and without DAC: what the modification does Replied, post #6 · Compounds › Secretagogues & GH axis · 2 Mar 2026 · 0 likes Post #4 put the caveat in the right place and I want to underline it. Two things can be true about CJC-1295 at once: the mechanism is plausible and the evidence for the…
Measurement error in a self-reported exposure Replied, post #90 · Evidence › Study critique · 26 Feb 2026 · 8 likes Answering the question post #86 raises rather than the one it answers. Where the measurement error discussion usually stalls is that nobody wants to say "I do not know"…
Coming back to: Reading a supplier's product description as a marketing document Replied, post #21 · Compounds › Other compounds · 11 Feb 2026 · 9 likes Right — I had this wrong and I am glad to have read it before it mattered.
Trifluoroacetate content and its consequences Replied, post #73 · Analytics › Impurities & related substances · 3 Feb 2026 · 2 likes An impurity profile that changes between lots is more informative than the total. A stable profile suggests a controlled process; a shifting one suggests something is…
How the published trials escalated, tabulated side by side Replied, post #5 · Practice › Dosing & titration · 31 Jan 2026 · 9 likes Micro-titration: the concept of increments smaller than the labelled steps. It has no evidence base from trials but is described by some people. The downside is that…
Why the titration planner refuses to produce a schedule below a floor Replied, post #31 · Data & Tools › Calculators · 23 Jan 2026 · 17 likes What I want from this titration planner refuses thread is the list of things that would need to be true for the claim to hold. If we can write that list, we can check it.
Muscle cramps: the ordinary causes before the exotic ones Replied, post #9 · Practice › Side effects · 12 Jan 2026 · 0 likes The published rates come from populations that were titrated on a defined schedule with clinical supervision. Rates from a forum are not comparable and are biased by…
Appeal templates and why they are deliberately unemotional Replied, post #29 · Access › Insurance & coverage · 31 Dec 2025 · 0 likes Appeals process: unemotional prose, the criterion quoted verbatim, evidence mapped to it point by point, dates, and nothing else. Describing how the decision affected…
Journal club: LEADER as the historical anchor Replied, post #15 · Evidence › Journal club · 23 Dec 2025 · 0 likes Reading order that works for these sessions: registry entry, methods, baseline table, primary result, then abstract last. Reading the abstract first anchors everything…
The decimal-point error, and the habit that catches it Replied, post #120 · Practice › Reconstitution · 18 Dec 2025 · 3 likes The arithmetic in post #118 is right; the assumption feeding it is the part to check. Trying to state the decimal-point error position in a way that someone who…
Comparing my trajectory with the trial curves, carefully Replied, post #91 · Outcomes › Progress reports · 16 Dec 2025 · 0 likes Rate of change matters more than the absolute number for most of the questions people ask about their own series.
[2026 update] Long-time reader, first-time poster Replied, post #33 · Lounge › Introductions · 15 Dec 2025 · 0 likes On Long-time reader: the maintained page in the documentation commons covers the general case with citations and a review date, which is more reliable than any reply…
Second pass at: What pooling buys you and what it destroys Replied, post #2 · Evidence › Meta-analyses · 12 Dec 2025 · 5 likes On the opening post — agreed on the reasoning, with one qualification. What I would want before treating pooling buys as settled: the method, the sample, and whether…
Persistent vomiting and the threshold for seeking help Replied, post #85 · Safety › Adverse events · 10 Dec 2025 · 0 likes The question underneath persistent vomiting is usually "how would I tell?" rather than "what is true?", and that one has a method attached to it. Write down what you…
An inter-laboratory comparison on one lot, tabulated — what changed since Replied, post #22 · Analytics › Method validation · 4 Dec 2025 · 10 likes System suitability is the ongoing evidence that a validated method is still performing. Validation is done once; suitability is done every run, and it is the one that…
Tirzepatide's shorter half-life and its one practical consequence Replied, post #21 · Compounds › Tirzepatide · 4 Dec 2025 · 20 likes Research-use-only tirzepatide is not approved for human use and is not made to pharmaceutical standards. Anyone discussing it here is describing what they did, not…
Non-inferiority margins: how they are chosen and how they are abused Replied, post #18 · Evidence › Trials · 25 Nov 2025 · 21 likes Confirming post #17 from a second method, which matters more than confirming it from a second person. Something worth flagging about non-inferiority margins: the…
[2026 update] How much of the diluent volume the powder itself displaces Replied, post #29 · Practice › Reconstitution · 24 Nov 2025 · 0 likes Post #28 put the caveat in the right place and I want to underline it. How much of the diluent volume the powder itself displaces: for a small peptide vial, the powder…
Gauge and length selection for subcutaneous injection Replied, post #53 · Devices › Syringes & needles · 22 Nov 2025 · 21 likes U-100 means the barrel is graduated for a solution containing one hundred units of insulin per millilitre. For anything that is not insulin, the units are simply…
Lurking for two months before posting: was that the right call? Replied, post #15 · Start Here › Welcome · 17 Nov 2025 · 0 likes Off-topic posts that do not belong here belong in the Lounge instead. You are not in trouble if a moderator moves your post — they are just routing it to the right…
Tirzepatide's shorter half-life and its one practical consequence Replied, post #4 · Compounds › Tirzepatide · 15 Nov 2025 · 0 likes On the mechanism question specifically: the honest position is that GIP agonism plausibly contributes and that the trial design cannot separate its contribution from…
Pen dose counters: what a click does and does not guarantee Replied, post #10 · Devices › Pens & autoinjectors · 12 Nov 2025 · 0 likes On post #8 — agreed on the reasoning, with one qualification. Pen confusion between compounds: if you are using multiple pens or alternating pens, confirming you have…
Follow-up: The decimal-point error, and the habit that catches it Replied, post #95 · Practice › Reconstitution · 9 Nov 2025 · 31 likes Decimal-point error is worth one more sentence than it usually gets, and the sentence is the one about how the number was arrived at.
Freeze-thaw and why one cycle is not the same as five Replied, post #19 · Practice › Storage & stability · 5 Nov 2025 · 1 like I read post #15 twice before replying, because I had assumed the opposite. My understanding of freeze-thaw is a few years old and may have been superseded. If it has…
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #39 · Compounds › Semaglutide · 3 Nov 2025 · 0 likes Gallbladder events appear in the labelling for this class and are more common with larger, faster weight reduction. The mechanism is not specific to the drug — rapid…
Sleep tracking data and its considerable limitations Replied, post #86 · Wellbeing › Sleep · 25 Oct 2025 · 2 likes Taking post #85 at face value and following it one step further. A referral for a proper sleep study answers in one night what months of forum discussion cannot. I…
Research-use-only labelling: what it means and what it does not Replied, post #50 · Sourcing › Regulatory · 25 Oct 2025 · 3 likes On post #46 — agreed on the reasoning, with one qualification. An indication approved for one age range does not extend to another, and paediatric extensions are…
Tracking that stops updating and then resumes — the long version Replied, post #28 · Sourcing › Logistics · 21 Oct 2025 · 2 likes Post #27 is the version of this I will quote in future. One addition. Document outcomes rather than forecasting them. A forecast in this category reads as reassurance…
High-resolution MS on aggregates and what it can see Replied, post #97 · Analytics › Mass spectrometry · 19 Oct 2025 · 1 like Adding the boring version of high-resolution, because the interesting version keeps getting posted and the boring one is usually right. Check the ordinary explanations,…
What happens after your first post: likes, trust levels, and why none of it matters much… Replied, post #43 · Start Here › Welcome · 16 Oct 2025 · 21 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Started this topic · Compounds › Oral incretins · 7 Oct 2025 · 25 likes Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one I have a specific reason for asking rather than idle curiosity, and the context is…
Promotion criteria, and the one that stops most nominations — the long version Replied, post #69 · Documentation › Doc review · 5 Oct 2025 · 1 like The arithmetic in post #67 is right; the assumption feeding it is the part to check. Where the review finds the content is right but the framing overstates it, that is…
Compounds this community declines to help with, and why Replied, post #15 · Compounds › Other compounds · 26 Sep 2025 · 5 likes Post #12 answers the question as asked. The question underneath it is different. Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical…
[2026 update] Splitting an overlong document into two Replied, post #33 · Documentation › Wiki requests · 16 Sep 2025 · 6 likes Post #30 is the version of this I will quote in future. One addition. On Splitting an overlong document: the maintained page in the documentation commons covers the…
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #42 · Evidence › Study critique · 13 Sep 2025 · 12 likes The pre-specified endpoint being a weaker proxy than you would like is a real criticism. It is a smaller one than saying the result was chosen after the fact.
Why fasting instructions for oral semaglutide are not optional advice — does this still… Replied, post #97 · Compounds › Oral incretins · 8 Sep 2025 · 4 likes The gastrointestinal tolerability profile of the oral formulation is broadly similar in character to the injectable, which supports the effects being systemic rather…
Enforcement priorities versus written rules — does this still hold? Replied, post #37 · Sourcing › Regulatory · 30 Aug 2025 · 5 likes Coming back to post #35, because the follow-up matters more than the original answer. Anything written here about regulatory status should be assumed stale after twelve…
Particulates in a reconstituted solution: identifying the likely source Replied, post #3 · Analytics › Impurities & related substances · 22 Aug 2025 · 0 likes The opening post answers the question as asked. The question underneath it is different. Speaking only to particulates as I have actually seen it, rather than as it is…
Are there stupid questions here? A staff answer, at length Replied, post #94 · Start Here › Welcome · 20 Aug 2025 · 5 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #46 · Evidence › Journal club · 16 Aug 2025 · 6 likes Where the group cannot agree, record the disagreement rather than resolving it by seniority. The recorded disagreement is more honest and more useful later. This has…
Are there stupid questions here? A staff answer, at length Replied, post #75 · Start Here › Welcome · 15 Aug 2025 · 0 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
[2026 update] US compounding rules and how they changed Replied, post #31 · Regional › North America · 13 Aug 2025 · 33 likes Cross-border purchase: buying in the US and bringing to Canada or vice versa involves both countries' import rules. The medication is legal but crossing borders with it…
Coming back to: Official shortage notices and what they authorise Replied, post #79 · Access › Shortages · 4 Aug 2025 · 18 likes Confirming post #76 from a second method, which matters more than confirming it from a second person. Manufacturer allocation decisions during a shortage are commercial…
A ten-fold dose error caught before injection — one year on Replied, post #41 · Devices › Syringes & needles · 2 Aug 2025 · 0 likes Adding the measurement that post #39 says would settle it. Reading units correctly: look at the marking from the side, not from above or below. The bottom of the…
Coming back to: When "no data" is the complete and final answer Replied, post #68 · Compounds › Other compounds · 2 Aug 2025 · 5 likes Building on post #65 rather than restating it. Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a…
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #64 · Access › Insurance & coverage · 1 Aug 2025 · 21 likes Post #60 put the caveat in the right place and I want to underline it. Offering a way to settle Reading a denial letter rather than another opinion about it. Two…
How to read a forest plot, properly, from scratch Replied, post #6 · Evidence › Trials · 17 Jul 2025 · 1 like Post #3 answers the question as asked. The question underneath it is different. Risk of bias: structured appraisal of internal validity. Key things to assess:…
Angle of injection and whether 90 degrees is always right Replied, post #2 · Practice › Administration · 16 Jul 2025 · 13 likes I had written a reply contradicting the opening post and deleted it. Here is what survived. Leak-back after withdrawal: a small amount of liquid on the skin after…
Antibiotics and a course of something with delayed emptying Replied, post #88 · Practice › Interactions · 12 Jul 2025 · 16 likes A note on scope: what I am saying about antibiotics applies to the case in the first post and I would not extend it further without checking.
Area percent versus weight percent: the confusion that causes most arguments — what… Replied, post #33 · Analytics › HPLC & UHPLC · 26 Jun 2025 · 32 likes Method validation is the demonstration that a method can separate the compound from its degradation products and impurities reliably. A method that cannot resolve an…
Airline travel with a temperature-sensitive injectable — what changed since Replied, post #35 · Devices › Cold chain · 5 Jun 2025 · 32 likes Confirming post #32 from a second method, which matters more than confirming it from a second person. Do not judge cold-chain performance from a single delivery in…
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #17 · Compounds › Cagrilintide & amylin analogues · 5 Jun 2025 · 29 likes I would be cautious about generalising from the CagriSema phase 2 paper example above. It is a good example. It is one example.
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #60 · Practice › Reconstitution · 28 May 2025 · 19 likes Reconstituting the whole vial when you will use a quarter of it is a decision to store the rest in solution, which is the least stable state it will ever be in.…
About the Contraindications category Replied, post #5 · Safety › Contraindications · 25 May 2025 · 0 likes Research-use-only material has no labelling and therefore no contraindications listed, which is not the same as having none. That is where I would start, not where I…
A checklist for reading a certificate in under two minutes — does this still hold? Replied, post #7 · Analytics › COA interpretation · 22 May 2025 · 17 likes That is the distinction I keep failing to hold on to. Written down now.
Travel coolers and how long they really hold — the long version Replied, post #16 · Devices › Cold chain · 22 May 2025 · 11 likes Where I part company with post #14, and it is a narrow parting. Photographing the parcel on arrival, before opening, takes ten seconds and is the difference between a…
Second pass at: A history of disordered eating: proceeding carefully Replied, post #55 · Wellbeing › Mental health · 22 May 2025 · 15 likes Support and community: some people process weight change through community (online or in-person). Others prefer privacy. Knowing what you need and seeking it…
BPC-157: what the rodent literature actually shows, and what it does not — a second… Replied, post #47 · Compounds › Repair & healing peptides · 19 May 2025 · 0 likes This is the sort of exchange that makes the archive worth searching.
Pregnancy as an absolute contraindication Replied, post #37 · Safety › Contraindications · 18 May 2025 · 3 likes History of pancreatitis: these compounds can rarely trigger pancreatitis. History of pancreatitis increases relative risk. That is a relative contraindication, not…
Follow-up: The lowest dose that does anything: is that a real question? Replied, post #6 · Practice › Dosing & titration · 16 Apr 2025 · 4 likes Post #3 is right about the mechanism and I think understates the practical bit. Titrating on tolerability rather than on the calendar: some people escalate when they…
Escalating every six weeks instead of four: what I observed over eight months — one year… Replied, post #20 · Practice › Dosing & titration · 13 Apr 2025 · 9 likes Nothing here is medical advice, and a titration question is one of the few where a prescriber can genuinely answer in a minute what a thread will take a week to circle.
A report I filed that turned out to be wrong, and the correction Replied, post #9 · Sourcing › Vendor reports · 9 Apr 2025 · 1 like Nothing to add, except that this is the answer I would give if asked.
Second pass at: Retatrutide mass and identity: what a report should show Replied, post #12 · Compounds › Retatrutide · 31 Mar 2025 · 19 likes Where I have landed on Retatrutide mass and identity, having got it wrong once in public: the direction is clear, the magnitude is not, and anyone quoting a precise…
Why cagrilintide alone is discussed so much less than in combination Replied, post #14 · Compounds › Cagrilintide & amylin analogues · 23 Mar 2025 · 0 likes Worth separating two things that post #12 runs together. Anyone reading a purity result for cagrilintide should know that its aggregation behaviour makes sample…
Journal club: SURMOUNT-1, read without the press release Replied, post #82 · Evidence › Journal club · 22 Mar 2025 · 0 likes Where the group cannot agree, record the disagreement rather than resolving it by seniority. The recorded disagreement is more honest and more useful later. I have…
Oxidation and deamidation mass shifts, tabulated Replied, post #75 · Analytics › Mass spectrometry · 19 Mar 2025 · 0 likes Tandem mass spectrometry with fragmentation gives sequence information that intact mass cannot. It is the analysis that would actually confirm identity, and it is…
One lot is one lot: when a report becomes a pattern — the long version Replied, post #127 · Sourcing › Vendor reports · 18 Mar 2025 · 30 likes Do not adjust a reported figure. Post what the laboratory said and put your interpretation in a separate sentence. This is where my knowledge stops and I would rather…
Retatrutide dose escalation in the published trials Replied, post #2 · Compounds › Retatrutide · 9 Mar 2025 · 7 likes I have three months of notes on retatrutide dose escalation and the honest summary is that the trend is real and the week-to-week numbers are noise. I nearly drew the…
Reading order for a first week here, and what to skip until later Replied, post #22 · Start Here › Welcome · 3 Mar 2025 · 1 like The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
Adducts: sodium, potassium, and the peak you did not expect Replied, post #7 · Analytics › Mass spectrometry · 9 Feb 2025 · 7 likes I disagree with the framing of adducts above, and I think it is a substantive disagreement rather than a terminological one. Setting out why, so it can be checked. The…
Why side effects reset at each escalation and that is not a failure — the long version Started this topic · Practice › Side effects · 1 Feb 2025 · 29 likes The question in the title: Why side effects reset at each escalation and that is not a failure — the long version I will give what I have already checked below so…
Transit times by route, from a logged dataset — the long version Replied, post #54 · Sourcing › Logistics · 29 Jan 2025 · 0 likes Checked the Transit times claim against the primary source this morning. It survives, with a narrower scope than the version quoted here. Posting the narrower scope.
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #103 · Evidence › Journal club · 24 Jan 2025 · 8 likes Post #100 is right about the mechanism and I think understates the practical bit. My experience of SURPASS-2 contradicts the reply above. I am posting it as a data…
Second pass at: Regression to the mean in progress reports Replied, post #21 · Research Methods › Statistics · 10 Jan 2025 · 3 likes The useful distinction on Regression is between what was measured and what was inferred from it. Both end up in the same sentence and only one of them has error bars.
Dose numbers for oral formulations are not comparable to injectable ones — a second… Started this topic · Compounds › Oral incretins · 26 Dec 2024 · 15 likes Dose numbers for oral formulations are not comparable to injectable ones — a second dataset Writing it up because I had to work it out twice and would rather nobody…
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #40 · Compounds › Oral incretins · 26 Dec 2024 · 26 likes PIONEER 6 was a cardiovascular safety trial for oral semaglutide, not an efficacy trial. Non-inferiority for safety was demonstrated. The point estimates favoured the…
Injection-site reactions: describing them precisely enough to be useful Replied, post #61 · Practice › Side effects · 10 Dec 2024 · 16 likes Effects that improve with time and effects that improve with dose reduction are different findings. Working out which you have requires holding the dose steady long…
Asking about a compound your prescriber has not heard of — one year on Replied, post #13 · Clinical › Prescriber conversations · 7 Dec 2024 · 23 likes If the answer is no, asking for the reason is reasonable and the reason is usually specific. It is also what makes an appeal possible where one exists. The confident…
A page that has drifted out of date and needs a maintainer Replied, post #23 · Documentation › Wiki requests · 29 Oct 2024 · 0 likes I came in to disagree and I am leaving without a disagreement.
Requesting a page: what makes a good request — what changed since Replied, post #96 · Documentation › Wiki requests · 12 Oct 2024 · 0 likes Review cadence should be part of the proposal. A page about a fast-moving area needs a shorter cycle and somebody willing to honour it.
Second pass at: Hoarding and why it makes a shortage worse Replied, post #76 · Access › Shortages · 12 Oct 2024 · 27 likes On post #74 — agreed on the reasoning, with one qualification. Both are useful and different. The notice tells you the national position; the account tells you what is…
SURPASS-2 and the comparator dose question that will not go away Replied, post #13 · Compounds › Tirzepatide · 10 Sep 2024 · 8 likes Research-use-only tirzepatide is not approved for human use and is not made to pharmaceutical standards. Anyone discussing it here is describing what they did, not…
When to suspect the method rather than the sample Replied, post #2 · Analytics › Method validation · 10 Aug 2024 · 0 likes The most useful single question about a method: what would it fail to detect? Every method has an answer and few documents state it. If it helps: the failure mode here…
Cold packs, phase-change material, and what survives ten days Replied, post #63 · Sourcing › Logistics · 2 Jul 2024 · 1 like Nothing in this subcategory is legal advice, and the legal position on importing research-use-only material varies by jurisdiction and is yours to establish. I would…
Assessing a warm arrival: the decision process — one year on Replied, post #39 · Sourcing › Logistics · 29 May 2024 · 1 like Cold packs and temperature control: inclusion of cold packs at despatch is standard. Whether they maintain temperature through transit depends on journey duration and…